World Pharma News

Bristol-Myers Squibb

Bristol-Myers SquibbBristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit

Bristol-Myers Squibb RSS Channel

Display # 
Title Published Date
Bristol-Myers Squibb establishes collaborative Immuno-Oncology Rare Population Malignancy (I-O RPM) program in the U.S. 04 August 2015
Lilly, Bristol-Myers Squibb Restructure Erbitux® (cetuximab) Collaboration in North America 16 April 2015
Bristol-Myers Squibb acquires exclusive license from Novo Nordisk for a discovery research program focused on autoimmune diseases 24 March 2015
FDA approves Opdivo (nivolumab) for the treatment of patients with previously treated metastatic squamous non-small cell lung cancer 05 March 2015
Bristol-Myers Squibb reports fourth quarter and full year 2014 financial results 27 January 2015
Bristol-Myers Squibb and California Institute for Biomedical Research (Calibr) sign worldwide research collaboration 05 January 2015
Bristol-Myers Squibb Foundation awards nine grants to support care for high-risk patients with hepatitis B and C in China and India 03 December 2014
Bristol-Myers Squibb and Five Prime Therapeutics announce exclusive clinical collaboration 25 November 2014
Bristol-Myers Squibb to construct a new large-scale biologics manufacturing facility in Ireland 14 November 2014
Bristol-Myers Squibb enters into agreement that provides an exclusive option to acquire F-star Alpha Ltd. and its novel HER2-targeted therapy 28 October 2014
Bristol-Myers Squibb and Pfizer announce charitable donations of more than $1 million to support cardiovascular education 22 September 2014
Allied Minds and Bristol-Myers Squibb form new enterprise 07 August 2014
Bristol-Myers Squibb reports second quarter 2014 financial results 25 July 2014
Bristol-Myers Squibb and Syngene International extend research collaboration 04 June 2014
Bristol-Myers Squibb ranks first on 2014 Best Corporate Citizens List 24 April 2014
Five Prime Therapeutics and Bristol-Myers Squibb sign collaboration agreement 17 March 2014
Bristol-Myers Squibb announces charitable donation of $1 million 04 March 2014
Bristol-Myers Squibb completes previously announced sale of global diabetes business to AstraZeneca 03 February 2014
Bristol-Myers Squibb Reports fourth quarter and full year 2013 financial results 26 January 2014
AstraZeneca and Bristol-Myers Squibb Diabetes Alliance provides $5 million grant for American Diabetes Association's Pathway to Stop Diabetes 16 January 2014

© World Pharma News 2006 - 2015

Top Desktop version